Experimental Molecule Reprograms Brain's Immune Defenses Against Alzheimer's

Researchers from Spain's Institute of Neurosciences and Switzerland's EPFL have identified an experimental molecule that can restore protective functions in brain immune cells affected by Alzheimer's disease. The discovery targets microglia, specialized immune cells in the brain that become dysfunctional during neurodegeneration. This breakthrough offers promising potential for slowing or halting disease progression by enhancing the brain's natural defense mechanisms. The findings represent a significant step toward developing new therapeutic approaches for Alzheimer's patients.
Originally published on
DiarioSalud.do
By Diario Salud Redacción
Read full article(opens in new tab)Fetched: June 18, 2026 at 10:12 AM



